Literature DB >> 35972956

COVID-19 infection and vaccination in immunodeficiency.

Eva Piano Mortari1,2, Federica Pulvirenti3.   

Abstract

During the last 2 years and a half, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, causing about 6 million deaths. Clinical manifestations are highly variable, ranging from entirely asymptomatic infection to multiorgan failure and death. The outcome in immunocompromised patients is still a matter of debate, and so are the optimal strategies to prevent or treat the infection in these high-risk populations. © Crown copyright 2022.

Entities:  

Keywords:  immunodeficiency diseases; infection; vaccination; virus

Mesh:

Year:  2022        PMID: 35972956      PMCID: PMC9384801          DOI: 10.1093/cei/uxac080

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  21 in total

1.  Guidelines for analysis of low-frequency antigen-specific T cell results: Dye-based proliferation assay vs 3H-thymidine incorporation.

Authors:  Daniela Di Blasi; Iris Claessen; Annelies W Turksma; Josine van Beek; Anja Ten Brinke
Journal:  J Immunol Methods       Date:  2020-11-03       Impact factor: 2.303

2.  T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies.

Authors:  Federica Pulvirenti; Stefano Di Cecca; Matilde Sinibaldi; Eva Piano Mortari; Sara Terreri; Christian Albano; Marika Guercio; Eleonora Sculco; Cinzia Milito; Simona Ferrari; Franco Locatelli; Concetta Quintarelli; Rita Carsetti; Isabella Quinti
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

3.  Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?

Authors:  David Baker; Amy MacDougall; Angray S Kang; Klaus Schmierer; Gavin Giovannoni; Ruth Dobson
Journal:  Clin Exp Immunol       Date:  2021-11-18       Impact factor: 5.732

4.  Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination.

Authors:  Filippo Fagni; Katja Schmidt; Daniela Bohr; Larissa Valor-Méndez; Fabian Hartmann; Koray Tascilar; Karin Manger; Bernhard Manger; Arnd Kleyer; David Simon; Georg Schett; Thomas Harrer
Journal:  RMD Open       Date:  2022-05

Review 5.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations.

Authors:  Ignacio Sanz; Chungwen Wei; Scott A Jenks; Kevin S Cashman; Christopher Tipton; Matthew C Woodruff; Jennifer Hom; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 6.  Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients.

Authors:  Antoine Lafarge; Asma Mabrouki; Elise Yvin; Swann Bredin; Yannick Binois; Raphael Clere-Jehl; Elie Azoulay
Journal:  Curr Opin Crit Care       Date:  2022-02-01       Impact factor: 3.687

7.  SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.

Authors:  Rita Carsetti; Isabella Quinti; Ane Fernandez Salinas; Eva Piano Mortari; Sara Terreri; Concetta Quintarelli; Federica Pulvirenti; Stefano Di Cecca; Marika Guercio; Cinzia Milito; Livia Bonanni; Stefania Auria; Laura Romaggioli; Giuseppina Cusano; Christian Albano; Salvatore Zaffina; Carlo Federico Perno; Giuseppe Spadaro; Franco Locatelli
Journal:  J Clin Immunol       Date:  2021-10-20       Impact factor: 8.317

8.  The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.

Authors:  Isabella Quinti; Franco Locatelli; Rita Carsetti
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

9.  Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.

Authors:  Tomas Milota; Marta Sobotkova; Jitka Smetanova; Marketa Bloomfield; Jana Vydlakova; Zita Chovancova; Jiri Litzman; Roman Hakl; Jiri Novak; Ivana Malkusova; Jana Hanzlikova; Dalibor Jilek; Beata Hutyrova; Vitezslav Novak; Irena Krcmova; Anna Sediva; Pavlina Kralickova
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

10.  Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.

Authors:  Dami A Collier; Isabella A T M Ferreira; Prasanti Kotagiri; Rawlings P Datir; Eleanor Y Lim; Emma Touizer; Bo Meng; Adam Abdullahi; Anne Elmer; Nathalie Kingston; Barbara Graves; Emma Le Gresley; Daniela Caputo; Laura Bergamaschi; Kenneth G C Smith; John R Bradley; Lourdes Ceron-Gutierrez; Paulina Cortes-Acevedo; Gabriela Barcenas-Morales; Michelle A Linterman; Laura E McCoy; Chris Davis; Emma Thomson; Paul A Lyons; Eoin McKinney; Rainer Doffinger; Mark Wills; Ravindra K Gupta
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.